CCS
ABEV icon

Crosspoint Capital Strategies’s Ambev ABEV Stock Holding History

Crosspoint Capital Strategies’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-33,664
Closed -$209K – 132
2015
Q4 		$209K Buy
33,664
+32,164
+2,144% +$157K 0.05% 226
2015
Q3 		$7K Hold
1,500
– – 0.01% 450
2015
Q2 		$9K Hold
1,500
– – ﹤0.01% 541
2015
Q1 		$9K Buy
+1,500
New +$9.31K ﹤0.01% 394

Other funds holding ABEV

VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crosspoint Capital Strategies's ABEV Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Ambev (ABEV) in Q1 2016, closing a stake of 33,664 shares — an estimated $209K sold.

Crosspoint Capital Strategies first reported a position in ABEV in Q1 2015 and held it in 4 quarters. The position peaked at $209K in Q4 2015. 300 funds tracked by Wall St. Rank hold ABEV as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Ambev position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 33,664 Ambev shares in Q1 2016, an estimated $209K.
  • Crosspoint Capital Strategies first reported a position in Ambev in Q1 2015 and held it in 4 quarters.
  • Crosspoint Capital Strategies's Ambev position peaked at $209K in Q4 2015.
  • 300 funds tracked by Wall St. Rank held Ambev as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.